ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

COG.GB Cambridge Cognition Holdings PLC

54.50
0.00 (0.00%)
26 Apr 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type Share ISIN Share Description
Cambridge Cognition Holdings PLC AQSE:COG.GB Aquis Stock Exchange Ordinary Share GB00B8DV9647
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 54.50 51.00 58.00 54.50 54.50 54.50 0.00 07:01:06
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Cambridge Cognition Holdings PLC Result of AGM (2393C)

24/06/2016 12:33pm

UK Regulatory


Cambridge Cognition (AQSE:COG.GB)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Cambridge Cognition Charts.

TIDMCOG

RNS Number : 2393C

Cambridge Cognition Holdings PLC

24 June 2016

Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')

Result of AGM

The neuroscience company Cambridge Cognition Holdings plc (AIM: COG), which develops and markets products and near patient technologies for cognitive assessment in clinical trials and healthcare applications held its Annual General Meeting yesterday at 11.00am at the registered office of the Company, Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25 9TU. All resolutions were duly passed.

At the meeting Steven Powell, Chief Executive Officer, provided shareholders with the following update:

"As we outlined in our Preliminary Results statement, we intend to accelerate revenue growth in both the academic research and pharmaceutical clinical trials business this year. We plan to achieve this through;

1). Investment in commercial infrastructure,

2). The launch of our online and wearable product platforms and

3). The introduction of partner products to maximise our sales channels exemplified by the recent announcements relating to the AnthroTronix DANA product and the MANUS pen for Parkinson's assessment.

We have made significant progress in the first half of 2016 towards implementation of our plan and we remain confident in the outlook for the year."

Enquiries:

 
 Cambridge Cognition      www.cambridgecognition.com 
  Holdings plc 
 Steven Powell, Chief                 Tel: 01223 810 
  Executive Officer                              700 
 Nick Walters, Chief 
  Financial Officer 
 
 finnCap Ltd (Nomad               Tel: 020 7220 0500 
  & Joint Broker) 
 Geoff Nash / Simon              (Corporate Finance) 
  Hicks 
 Alice Lane                      (Corporate Broking) 
 
 Hybridan LLP (Joint              Tel: 020 3764 2341 
  Broker) 
 Claire Noyce                    (Corporate Broking) 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGAKQDNDBKDDAB

(END) Dow Jones Newswires

June 24, 2016 07:33 ET (11:33 GMT)

1 Year Cambridge Cognition Chart

1 Year Cambridge Cognition Chart

1 Month Cambridge Cognition Chart

1 Month Cambridge Cognition Chart

Your Recent History

Delayed Upgrade Clock